Milwaukee, WI 53233, US
Medical Devices & Equipment
www.novascan
NovaScan LLC has developed a technology that detects cancer real time in human tissue, both ex vivo and in vivo. Our first target disease is breast cancer, and recently we have investigated the use of this technology for skin cancer, with other types of cancer to follow (such as thyroid cancer).
There are currently two devices in development: a hand-held probe (FastPath™) and an Electrical Anomaly Mammogram (EAM), These devices have demonstrated excellent precision in clinical studies and are being further tested to bring them to market.
NovaScan LLC has developed a technology that detects cancer real time in human tissue, both ex vivo and in vivo. Our first target disease is breast cancer, and recently we have investigated the use of this technology for skin cancer, with other types of cancer to follow (such as thyroid cancer).
There are currently two devices in development: a hand-held probe (FastPath™) and an Electrical Anomaly Mammogram (EAM), These devices have demonstrated excellent precision in clinical studies and are being further tested to bring them to market.
Prior Year Revenue | Current Year Revenue | Next Year Revenue |
---|---|---|
Sign up as Investor | Sign up as Investor | Sign up as Investor |
Company Age | Employees | Sub-Industry |
---|---|---|
11 years, 8 months | 3 | Surgical |
Company Type | Stock Exchange | Stock Symbol |
---|---|---|
Privately-Held | – | – |